The largest database of trusted experimental protocols

Staphylococcus aureus protein a

Manufactured by Merck Group
Sourced in United States

Staphylococcus aureus protein A is a cell wall-associated protein produced by the bacterium Staphylococcus aureus. It has the ability to bind to the Fc region of immunoglobulins, particularly IgG. This property makes it a useful tool in various laboratory applications, such as affinity chromatography and immunoassays.

Automatically generated - may contain errors

6 protocols using staphylococcus aureus protein a

1

Recombinant Phospholipase A2 Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PLA2G1B was produced in E. coli (gift of Gerard Lambeau, purity > 98%) or CHO-S (purity > 98%, Merck or GTP). Human proPLA2G1B, PLA2GIIA, PLA2GIID, PLA2GX, and WT and H48Q porcine PLA2G1B were produced in E. coli (gift of Gerard Lambeau, purity > 98%). Recombinant HIV-1 gp41 MN protein was obtained from Antibodies online (gp41 MN (565-771Delta642-725), containing a deletion to remove the transmembrane domain of the protein, ABIN2129703, lot 93-482, purity > 95%) and the 3S peptide NH2-PWNASWSNKSLDDIW-COOH, 3S-like peptide OmpA Pg NH2-SGEGGWSNGSLVDIM-COOH, and scrambled 3S NH2-WNWDSKILSDPAWNS-COOH peptide were ordered from Covalab (purity > 98%). The HCV core protein was obtained from Prospec (HCV-011, purity > 95%) in PBS buffer with 0.002% SDS and the specificity of the effect due to HCV core protein evaluated by comparison with a similar dilution of PBS-0.002% SDS. Staphylococcus aureus protein A was obtained from Sigma (P6031). sPLA2 inhibitors were obtained from several providers: Pentapeptide (sPLA2-IIA Inhibitor I, 525145, Calbiochem, ordered from VWR), Varespladib (LY315920, S1110, Selleck ordered from Euromedex), and sPLA2R1 (murine soluble receptor, 5367-PL-050, R&D Systems).
+ Open protocol
+ Expand
2

Quantifying Influenza HA-Specific IgG B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A/California/07/2009 (H1N1) influenza HA‐specific IgG‐secreting B cells were performed as previously described 21. Briefly, PBMC were stimulated with a mixture of pokeweed mitogen (Sigma), Staphylococcus aureus protein A (Sigma) and CpG ODNs (Invivogen, San Diego, CA, USA) for 6 days before enzyme‐linked immunospot (ELISPOT) assay. H1N1 HA protein (Protein Sciences, Meriden, CT, USA) was used to coat the plate (Millipore, Watford, UK), and immunoglobulin (Ig)G‐ or IgA‐paired antibodies (Mabtech/Oxford lmmunotec Limited, Abingdon, UK) were used to reveal. ELISPOT readouts were expressed as the number of HA‐specific IgG or IgA ASC/106 PBMC.
+ Open protocol
+ Expand
3

ChIP Assay for Chromatin Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The detailed procedure of the ChIP assay has been described in our previous papers [25 (link),28 (link),29 (link)]. Briefly, C2C12 cells were washed, fixed in formaldehyde (1%, w/v), and sonicated to shear chromatin. Specific antibody was added to the cleared lysate and the binding was allowed to proceed at 4°C overnight before Staphylococcus aureus Protein A (Sigma, #P7155) was added to capture the immune complex and then washed extensively. Then, the immune complex was eluted and the released DNA was extracted with phenol/chloroform twice and further purified using a PCR purification Kit (Geneaid). The primer sets used in the ChIP assay are listed in Supplementary Table S3.
+ Open protocol
+ Expand
4

Staphylococcus aureus Biofilm Disruption

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pre-formed biofilms in chambered coverglass were also exposed to 10% SaF that had undergone various manipulations as described below. Staphylococcus aureus protein A was purchased from Sigma and used at a final concentration of 50 μg/mL. Biofilms treated with tobramycin (Sigma) were exposed for 24 h to 1000 µg/mL of the drug.
+ Open protocol
+ Expand
5

Isolation and Characterization of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents were obtained from the following sources: collagenase P, bovine serum albumin (BSA), Ficoll 400, trypan blue, 4-(2-hydroxyethyl)-1 piperazineethanesulfonic acid (HEPES), poly-L-lysine, Staphylococcus aureus protein A, trypsin, insulin, guinea-pig complement, nickel chloride (II), and all salts of electrophysiological recordings from Sigma-Aldrich (St. Louis, MO, USA); mibefradil, nifedipine, anti-VGCC rabbit polyclonal IgG from Alomone Labs (Jerusalem, Israel); FITC-conjugated anti-guinea pig, and Alexa Fluor 647-conjugated anti-rabbit IgG from Jackson ImmunoResearch (West Grove, USA). Tetrodotoxin from Calbiochem (La Jolla, CA, USA); TTA-A2 kindly donated by Merck (West Point, PA, USA) to Dr. Juan Carlos Gomora; tissue culture dishes from Corning (Corning, NY, USA); Hanks’ balanced salt solution, RPMI-1640 salts, and penicillin–streptomycin solution, fetal bovine serum, and L-glutamine solution from Thermo Fisher Scientific Inc. (Massachusetts, USA).
+ Open protocol
+ Expand
6

Isolation and Culture of Primary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents were obtained from the following sources: Hank's balanced salt solution (HBSS), ethylene glycolbis[β-aminoethylether]N,N,N′,N′-tetraacetic acid] (EGTA), Ficoll 400, trypan blue, poly-l-lysine, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Staphylococcus aureus protein A, and trypsin from Sigma-Aldrich; collagenase P from Roche; DMEM salts, penicillinstreptomycin solution, Ham F10 medium, L-glutamine solution, fetal bovine serum (FBS), and guinea pig complement from Life Technologies; bovine serum albumin lyophilized powder (BSA) from United States Biological (Swampscott, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!